Definitive Contract 75F40120C00207
Award Date
9/30/20
Potential Completion Date
9/29/24
Potential Value
$1.5M
Federal Agency
Food and Drug Administration
Awardee
Georgia TECH Research Corp
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30318, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,237,710.00 definitive contract awarded by the Food and Drug Administration (FDA) to Georgia Tech Research Corporation (Georgia Tech) for research and development related to real-time microfluidic cell sensing and sorting to evaluate drug resistance in leukemia cells. The contract does not have a set-aside designation. Georgia Tech, a non-profit research organization and state institution of higher education, has a history of delivering a wide range of research, engineering, and...
This is a $2,014,369 fixed-price contract awarded by the Food and Drug Administration (FDA) to Georgia Tech Research Corporation (Georgia Tech) on September 28, 2022. The contract aims to evaluate and promote the use of cell- and tissue-based assays that more accurately represent human susceptibility to adverse reactions compared to animal models, and predict thresholds of toxicological concerns. This is part of the FDA's Broad Agency Announcement (BAA) focused on advancing regulatory science in...
The Department of Health and Human Services Food and Drug Administration awarded a $179,999.00 firm fixed price purchase order to the University of Georgia Research Foundation (UGA Research Foundation), a non-profit organization that manages sponsored programs at the University of Georgia. The contract is for research on the prevalence and seasonal dynamics of bacterial foodborne pathogens in agricultural animal production and pristine environments in the state of Georgia. The contract does...
The Department of Health and Human Services Food and Drug Administration awarded a $179,999.00 firm fixed-price purchase order to the University of Georgia Research Foundation, Inc. (UGA Research Foundation), a non-profit organization, to study the prevalence and seasonal dynamics of bacterial foodborne pathogens in agricultural, animal production, and pristine environments in the state of Georgia. The contract has a completion date of September 26, 2023. No set-aside designation was used.
This is a $1,904,355.00 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA), a civilian government agency, to the Institute Of Quantitative Systems Pharmacology, a non-profit organization. The contract is for basic and applied research with two key objectives: (1) to test the hypothesis that variabilities in nanoparticle (NP) properties and tumor targets cause uncertainties in "FORMULA", and (2) to develop computational models to predict the...
This is a firm fixed-price definitive contract awarded by the U.S. Food and Drug Administration (FDA) to the University of Georgia Research Foundation, Inc. (UGA Research Foundation) for a project titled "FSSWP#14 SALMONELLA SOURCE ATTRIBUTION BY MACHINE LEARNING AND WHOLE GENOME SEQUENCING". The contract has a ceiling value of $298,914.00 and a performance period ending on September 29, 2023. The contract is not set aside for any specific business category. UGA Research Foundation...
This is a $150,000 firm fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Georgia Tech Research Corporation, doing business as the Office of Sponsored Programs. The contract is for technical services and does not have a set-aside designation. Georgia Tech Research Corporation is a non-profit research organization and state institution of higher education that provides a range of research,...
This is a $345,000.00 definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the Georgia Tech Research Corporation, also known as the Office of Sponsored Programs. The contract is for FY 2020 COVID-19 Broad Agency Announcement (BAA) Topic 1 research and was awarded on March 15, 2021, with a completion date of June 30, 2023. Georgia Tech Research Corporation is a non-profit research organization and state institution of higher education associated with the...
This is a $5,000,001.00 definitive contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Institute of Technology (MIT) for "APPLICATION OF SMART DATA ANALYTICS FOR BIOMANUFACTURING." The contract has no set-aside designation and is a cost-type contract without fee. The contract was awarded under the FDA's Broad Agency Announcement for Advanced Regulatory Science, which solicits research and development proposals across various regulatory science areas to...
This contract award, with a ceiling value of $253,242.00, was issued by the Centers for Disease Control and Prevention (CDC) to the Georgia Tech Research Corporation (GTRC), a non-profit research organization and state institution of higher education associated with the Georgia Institute of Technology. The contract is for OPTIMIZING THERAPEUTIC STRATEGIES and does not have a set-aside designation. GTRC has a history of performing research, engineering, and technical services for various...